Cerebral XXXX is an imaging prognostic marker for revascularization treatment of @entity2500 .

@entity1 @entity15213 @entity64 @entity6 @entity63 @entity2500 @entity729 @entity385
BACKGROUND AND PURPOSE: To study the significance of @entity729 as a prognostic marker for acute @entity63 @entity64 @entity1 undergoing revascularization treatment after @entity2500 . METHODS: @entity1 with @entity2500 , who underwent intravenous and/or intra-arterial revascularization treatment, were enrolled. Intracranial @entity729 scores were calculated by counting calcified intracranial arteries among major seven arteries on computed tomographic angiography. @entity1 were divided into high ( @entity15213 ; score >= 3) or low calcification burden (LCB; score <3) groups. Demographic, imaging, and outcome data were compared, and whether @entity15213 is a prognostic factor was evaluated. Grave prognosis was defined as modified Rankin Scale 5-6 for this study. RESULTS: Of 80 enrolled @entity1 , the @entity15213 group comprised 15 @entity1 , who were older, and more commonly had @entity6 than @entity1 in the LCB group. Initial National Institutes of Health @entity64 Scale (NIHSS) scores did not differ ( @entity15213 13.3  2.7 vs. LCB 14.6  3.8) between groups. The final good reperfusion after revascularization treatment (thrombolysis in @entity385 score 2b-3, @entity15213 66.7% vs. LCB 69.2%) was similarly achieved in both groups. However, the @entity15213 group had significantly higher NIHSS scores at discharge (16.0  12.3 vs. 7.9  8.3), and more frequent grave outcome at 3 months (57.1% vs. 22.0%) than the LCB group. @entity15213 was proven as an independent predictor for grave outcome at 3 months when several confounding factors were adjusted (odds ratio 4.135, 95% confidence interval, 1.045-16.359, P=0.043). CONCLUSIONS: Intracranial @entity15213 was associated with grave prognosis in @entity1 who have undergone revascularization for @entity2500 .
